Researchers have likely found a new way to make the body make beneficial proteins, including some highly effective antibodies that are usually difficult to produce, by reprogramming the immune system. The study leader said that human stem cells that were modified in mice led to the emergence of functional immune cells, which is "a step that shows the feasibility of manufacturing life-saving proteins."
Published on: 04/17/2026 - 08:13
Researchers have reported that they have come up with a new way to make the body make useful proteins and highly effective antibodies, by reprogramming the immune system.
Traditional vaccines stimulate immune cells called B cells to produce antibodies that recognize germs. Some viruses, such as the human immunodeficiency virus that causes AIDS, can protect their most vulnerable parts behind sugar molecules that resemble the body's own tissues and are therefore largely ignored by the immune system.
Stem cell programming
So-called antibodies with a broad neutralizing effect can bypass these shields, but they usually come from cells that are rarely produced and arise only after a long and complex process of mutations. The researchers explained in the journal Science that most people never produce them, even if they are exposed to antigens through careful vaccination programs.
The researchers wondered whether they could permanently install instructions for antibodies with a broad neutralizing effect in the stem cells that produce B cells. If these stem cells are programmed correctly, every B cell they subsequently produces will carry the same blueprint for producing antibodies with a broad neutralizing effect, and will be ready to be activated by vaccination.
The team used gene editing tools (CRISPR) to insert the genetic blueprint to produce rare and protective antibodies with a broad neutralizing effect directly into immature stem cells, and then injected these cells into mice. These stem cells later developed into B cells programmed to produce genetically modified antibodies.
"Life-saving proteins"
Human stem cells modified using the same approach also gave rise to functional immune cells, suggesting that this approach may one day work in humans, the researchers said.
Harald Hartwiger, study leader from Rockefeller University, said that there are potential uses for these technologies in the future to deal with a wide range of health problems.
He added, "Among them will of course be antibodies to HIV, but also solutions that treat protein deficiencies and metabolic diseases, in addition to antibodies to treat inflammatory diseases or influenza, or those specific to cancer."
"This is a step in that direction, showing the feasibility of manufacturing life-saving proteins," he said.
Only a few dozen modified stem cells transplanted into mice were needed to stimulate the production of large quantities of antibodies with a broad neutralizing effect that persisted for a long time.
This method succeeded in generating antibodies to HIV, influenza, and malaria, according to an opinion article published with the report.
France 24/Reuters
Keywords related to the article
The content you want to browse is no longer in service or is currently unavailable.




